In this study, we designed and prepared a new anti-PSMA immunotoxin molecule based on the sdAb JVM and the improved PE toxin PE24X7 and evaluated the potential of this molecule for PCa treatment through detailed cell- and animal-based experiments. The gene discussed is FOLH1; the disease is posterior cortical atrophy.